{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:55:38Z","timestamp":1790690138847,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00871-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:03:59Z","timestamp":1782713039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory responses in HIV-1 genetic subtypes in relationship with anti-retroviral drug resistance in Minna, Niger State, North Central Nigeria"],"prefix":"10.1186","volume":"27","author":[{"given":"Ndukwe Arua","family":"Kalu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew Folaranmi","family":"Olaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pius Omoruyi","family":"Omosigho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bukhari Isah","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewean Chukwuma","family":"Omoruyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isah Sadiq","family":"Yelwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyare Godfrey","family":"Innocent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu Udechukwu","family":"Aka-Okeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyu Mohammed","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Alhaji","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"871_CR1","doi-asserted-by":"crossref","unstructured":"Jiang X, Zhou Q, Li Y. Inflammation driven resistance in HIV 1 infection: Role of chronic immune activation. Journal of Immunology Research, 2021, 2021: 5563734.","DOI":"10.1155\/2021\/7316456"},{"key":"871_CR2","doi-asserted-by":"crossref","first-page":"799008","DOI":"10.3389\/fimmu.2022.957797","volume":"13","author":"JA Garcia","year":"2022","unstructured":"Garcia JA, Ruiz Mateos E, Ferrando Mart\u00ednez S, Leal M. Integrase strand transfer inhibitors and resistance: Current knowledge and future challenges. Front Immunol. 2022;13:799008.","journal-title":"Front Immunol"},{"issue":"5","key":"871_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/COH.0000000000000693","volume":"16","author":"CA Hartana","year":"2021","unstructured":"Hartana CA, Yu XG. Immunological effector mechanisms in HIV 1 elite controllers. Curr Opin HIV AIDS. 2021;16(5):243\u20138.","journal-title":"Curr Opin HIV AIDS"},{"key":"871_CR4","first-page":"Article57","volume":"40","author":"V Kouamou","year":"2021","unstructured":"Kouamou V, Ndhlovu CE, Katzenstein D, Manasa J. Rapid HIV 1 drug resistance testing in a resource limited setting: The Pan Degenerate Amplification and Adaptation assay (PANDAA). Pan Afr Med J. 2021;40:Article57.","journal-title":"Pan Afr Med J"},{"key":"871_CR5","unstructured":"UNAIDS. Global HIV & AIDS Statistics \u2014 Fact Sheet. 2024. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"871_CR6","unstructured":"WHO. HIV Drug Resistance. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-drug-resistance."},{"issue":"2","key":"871_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/v16020219","volume":"16","author":"W Mu","year":"2024","unstructured":"Mu W, Patankar V, Kitchen S, Zhen A. Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection. Viruses. 2024;16(2):219.","journal-title":"Viruses"},{"issue":"2","key":"871_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/QAD.0000000000003413","volume":"37","author":"GG Aliyu","year":"2023","unstructured":"Aliyu GG, Lawton JG, Mitchell AB, Abimiku AG, Jelpe T, Bassey O, Riedel DJ, Swaminathan M, Chang JC, DeVos JR, Patel H, Charurat ME, Stafford KA, NAIIS Study Group. Prevalence of HIV drug resistance in Nigeria: Results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load. AIDS. 2023;37(2):333\u20139.","journal-title":"AIDS"},{"key":"871_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijregi.2022.03.007","volume":"3","author":"A Kapaata","year":"2022","unstructured":"Kapaata A, Balinda SN, Hare J, et al. Infection with HIV 1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A. IJID Reg. 2022;3:89\u201395.","journal-title":"IJID Reg"},{"issue":"3","key":"871_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"key":"871_CR11","unstructured":"Akahome P. HIV 1 subtypes. Aidsmap. 2024. https:\/\/www.aidsmap.com\/about-hiv\/hiv-1-subtypes."},{"key":"871_CR12","unstructured":"Gilroy SA. HIV infection and AIDS. Medscape. 2025."},{"issue":"7","key":"871_CR13","first-page":"1297","volume":"224","author":"JS Ferris","year":"2021","unstructured":"Ferris JS, Wolters PL, Jacobs E, et al. Inflammation and immune activation as mediators of HIV persistence and resistance: Implications for novel therapies. J Infect Dis. 2021;224(7):1297\u2013307.","journal-title":"J Infect Dis"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"102098","DOI":"10.1016\/j.eclinm.2023.102098","volume":"62","author":"AA Onovo","year":"2024","unstructured":"Onovo AA, Duricki DA, White RG, Mikkelsen EM. Estimation of HIV prevalence and burden in Nigeria: A Bayesian predictive modelling study. eClinicalMedicine. 2024;62:102098.","journal-title":"eClinicalMedicine"},{"key":"871_CR15","doi-asserted-by":"crossref","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN, R\u00f6nsholt FF, Pett S, Vjecha MJ, French MA, Lundgren JD. INSIGHT SMART, ESPRIT, and SILCAAT Study Groups. Factors associated with plasma IL 6 levels during HIV infection. J Infect Dis, 2015; 212(4): 585\u201395.","DOI":"10.1093\/infdis\/jiv123"},{"key":"871_CR16","doi-asserted-by":"crossref","unstructured":"Kaginkar S, Remling Mulder L, Sahoo A et al. Assessing HIV 1 subtype C infection dynamics, therapeutic responses and reservoir distribution using a humanized mouse model. Front Immunol, 2025; 16.","DOI":"10.3389\/fimmu.2025.1552563"},{"issue":"8","key":"871_CR17","first-page":"529","volume":"21","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zhang P, Yu X. Broadly neutralizing antibodies against HIV 1: Mechanisms and implications for vaccine design. Nat Rev Immunol. 2021;21(8):529\u201341.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"871_CR18","first-page":"741","volume":"19","author":"K Anastos","year":"2018","unstructured":"Anastos K, Hoover DR, Shi Q, Dusingize JC, Sinayobye JD, Kiefer EM. Longitudinal evaluation of markers of inflammation in HIV positive and HIV negative Rwandan women. HIV Med. 2018;19(10):741\u201351.","journal-title":"HIV Med"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-031-59815-9_18","volume":"1448","author":"N Erdmann","year":"2024","unstructured":"Erdmann N, Heath SL. Cytokine storm syndrome as a manifestation of primary HIV infection. Adv Exp Med Biol. 2024;1448:269\u201374.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"871_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/jiw173","volume":"214","author":"\u00c1H Borges","year":"2016","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN, Neaton JD, Grund B, Neuhaus J, Vjecha MJ, Calmy A, Koelsch KK, Lundgren JD, Study INSIGHTSMART, ESPRIT Groups. Interleukin 6 is a stronger predictor of clinical events than high sensitivity C reactive protein or D dimer during HIV infection. J Infect Dis. 2016;214(3):408\u201316.","journal-title":"J Infect Dis"},{"issue":"1","key":"871_CR21","first-page":"1205","volume":"13","author":"N Dube","year":"2023","unstructured":"Dube N, Mohale R, Jere KC. Transmitted drug resistance among ART na\u00efve HIV infected individuals in Sub Saharan Africa: A systematic review and meta analysis. J Global Health. 2023;13(1):1205\u201316.","journal-title":"J Global Health"},{"issue":"1","key":"871_CR22","first-page":"92","volume":"21","author":"J Hemelaar","year":"2021","unstructured":"Hemelaar J, Elangovan R, Yun J, et al. Global and regional molecular epidemiology of HIV 1, 1990\u20132019: A systematic review, global survey, and trend analysis. Lancet Infect Dis. 2021;21(1):92\u2013107.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"871_CR23","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1007\/s10461-022-03610-y","volume":"26","author":"CD Agegnehu","year":"2022","unstructured":"Agegnehu CD, Techane MA, Mersha AT, Atalell KA. Burden and associated factors of virological failure among people living with HIV in Sub Saharan Africa: A systematic review and meta-analysis. AIDS Behav. 2022;26(10):3327\u201336.","journal-title":"AIDS Behav"},{"issue":"1","key":"871_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/QAD.0000000000003098","volume":"36","author":"PE Oluniyi","year":"2022","unstructured":"Oluniyi PE, Ajogbasile FV, Zhou S, Akintunwa F, Polyak I, Ake CS, Tovanabutra JA, Iroezindu S, Rolland M, M., Happi CT. HIV 1 drug resistance and genetic diversity in a cohort of people with HIV 1 in Nigeria. AIDS. 2022;36(1):137\u201346.","journal-title":"AIDS"},{"issue":"7","key":"871_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/QAD.0000000000000184","volume":"28","author":"D Fuster","year":"2014","unstructured":"Fuster D, Cheng DM, Quinn EK, Armah KA, Saitz R, Freiberg MS, Samet JH, Tsui JI. Inflammatory cytokines and mortality in a cohort of HIV infected adults with alcohol problems. AIDS. 2014;28(7):1059\u201364.","journal-title":"AIDS"},{"key":"871_CR26","unstructured":"Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013 Winter;6(1):14\u20137. PMID: 24834239; PMCID: PMC4017493."},{"issue":"9","key":"871_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/09564624221106523","volume":"33","author":"MO Oluwalana","year":"2022","unstructured":"Oluwalana MO, Awolude OA, Gao Z, Daley PK. The epidemiology of delayed HIV diagnosis in Ibadan, Nigeria. Int J STD AIDS. 2022;33(9):829\u201336. https:\/\/doi.org\/10.1177\/09564624221106523.","journal-title":"Int J STD AIDS"},{"issue":"10","key":"871_CR28","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1007\/s10461-022-03610-y","volume":"26","author":"CD Agegnehu","year":"2022","unstructured":"Agegnehu CD, Techane MA, Mersha AT, Atalell KA. Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. AIDS Behav. 2022;26(10):3327\u201336. https:\/\/doi.org\/10.1007\/s10461-022-03610-y . Epub 2022 Apr 13. PMID: 35416596.","journal-title":"AIDS Behav"},{"issue":"1","key":"871_CR29","first-page":"15","volume":"41","author":"NK Wardhani","year":"2023","unstructured":"Wardhani NK, Putri DA, Santoso S. The Impact of Educational Attainment on Health Literacy and Medication Adherence Among Patients with Chronic Illnesses: A Systematic Review. J Health Educ Res Dev. 2023;41(1):15\u201328.","journal-title":"J Health Educ Res Dev"},{"key":"871_CR30","doi-asserted-by":"crossref","unstructured":"Torrone EA, Morrison CS, Chen P-L, Kwok C, Francis SC, Hayes RJ. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med, 2018; 15(2).","DOI":"10.1371\/journal.pmed.1002511"},{"key":"871_CR31","doi-asserted-by":"publisher","first-page":"Article10","DOI":"10.11604\/pamj.2019.32.10.7508","volume":"32","author":"C Anyaike","year":"2019","unstructured":"Anyaike C, Atoyebi OA, Musa OI, Bolarinwa OA, Durowade KA, Ogundiran A, Babatunde OA. Adherence to combined antiretroviral therapy (cART) among people living with HIV\/AIDS in a tertiary hospital in Ilorin, Nigeria. Pan Afr Med J. 2019;32:Article10.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"871_CR32","first-page":"111","volume":"27","author":"AM Wensing","year":"2019","unstructured":"Wensing AM, Calvez V, Ceccherini-Silberstein F, et al. 2019 update of the drug resistance mutations in HIV-1. Top Antiviral Med. 2019;27(3):111\u201321.","journal-title":"Top Antiviral Med"},{"issue":"3","key":"871_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/jiw173","volume":"214","author":"\u00c1H Borges","year":"2016","unstructured":"Borges \u00c1H, O\u2019Connor JL, Phillips AN, Neaton JD, Grund B, Neuhaus J, Vjecha MJ, Calmy A, Koelsch KK, Lundgren JD, INSIGHT SMART Study and ESPRIT Groups. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection. J Infect Dis. 2016;214(3):408\u201316.","journal-title":"J Infect Dis"},{"issue":"2suppl","key":"871_CR34","first-page":"S1","volume":"2","author":"E Choy","year":"2017","unstructured":"Choy E, Rose-John S. Interleukin-6 as a multifunctional regulator: Inflammation, immune response, and fibrosis. J Scleroderma Relat Disorders. 2017;2(2suppl):S1\u20135.","journal-title":"J Scleroderma Relat Disorders"},{"issue":"7","key":"871_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/cr.2013.74","volume":"23","author":"X Pan","year":"2013","unstructured":"Pan X, Baldauf H-M, Keppler OT, Fackler OT. Restrictions to HIV-1 replication in resting CD4\u2009+\u2009T lymphocytes. Cell Res. 2013;23(7):876\u201385.","journal-title":"Cell Res"},{"issue":"2","key":"871_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0253-7184.192127","volume":"37","author":"A Vishwanath","year":"2016","unstructured":"Vishwanath A, Quaiser S, Khan R. Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J sexually transmitted Dis AIDS. 2016;37(2):123\u20138.","journal-title":"Indian J sexually transmitted Dis AIDS"},{"issue":"17","key":"871_CR37","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.3390\/ijms25179434","volume":"25","author":"SJ Naidoo","year":"2024","unstructured":"Naidoo SJ, Naicker T. The enigmatic interplay of interleukin-10 in the synergy of HIV infection comorbid with preeclampsia. Int J Mol Sci. 2024;25(17):9434.","journal-title":"Int J Mol Sci"},{"key":"871_CR38","unstructured":"Ngangali JP, Mutesa L, Nsanzimana S, Munyemana JB, Injera EW, Kirtika P, Gatare S, Rutayisire R, Ndishimye IdV, Ndishimye P, Ntagwabira E, Nkinda L, Chemtai AK. The interleukin-6 and interleukin-10 plasma levels: The driver of immune dysfunction and chronic inflammation in HIV infection. J Infect Dis Prev Med, 2021; 9(11)."},{"key":"871_CR39","first-page":"1","volume":"71","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, Albini A. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Cytokine Growth Factor Rev. 2023;71:1\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"871_CR40","first-page":"361","volume":"22","author":"CA Hunter","year":"2022","unstructured":"Hunter CA. The multifaceted roles of IL-6 in immunity and inflammation. Nature Reviews Immunol. 2022;22(6):361\u201373.","journal-title":"Nature Reviews Immunol"},{"issue":"7","key":"871_CR41","first-page":"1011","volume":"50","author":"T Sokoya","year":"2023","unstructured":"Sokoya T, Steel HC, Nieuwoudt M, Rossouw TM. HIV as a Cause of Immune Activation and Premature Aging. Immuno-Inflammatory Responses Chronic Disease. 2023;50(7):1011.","journal-title":"Immuno-Inflammatory Responses Chronic Disease"},{"key":"871_CR42","unstructured":"Sandler NG, Douek DC. Chronic Immune Activation and HIV Persistence: Mechanisms and Implications for Therapy. Nature Reviews Immunology, 2022; 22(6): 337\u2013348. https:\/\/doi.org."},{"issue":"7","key":"871_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/jiu206","volume":"210","author":"SA Vaidya","year":"2014","unstructured":"Vaidya SA, Korner C, Sirignano MN, Amero M, Bazner S, Rychert J, Allen TM, Rosenberg ES, Bosch RJ, Altfeld M. Tumor necrosis factor \u03b1 is associated with viral control and early disease progression in patients with HIV type 1 infection. J Infect Dis. 2014;210(7):1042\u20136.","journal-title":"J Infect Dis"},{"issue":"4\u20135","key":"871_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cytogfr.2012.05.005","volume":"23","author":"MA Reuter","year":"2012","unstructured":"Reuter MA, Pombo C, Betts MR. Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. Cytokine Growth Factor Rev. 2012;23(4\u20135):181\u201391.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"871_CR45","first-page":"345","volume":"22","author":"J Esbj\u00f6rnsson","year":"2022","unstructured":"Esbj\u00f6rnsson J, Mild M, Medstrand P. Impact of HIV Genetic Diversity on Global Epidemic Spread. Lancet Infect Dis. 2022;22(6):345\u201356.","journal-title":"Lancet Infect Dis"},{"key":"871_CR46","unstructured":"Akahome P. HIV-1 subtypes. Aidsmap. 2024. https:\/\/www.aidsmap.com\/about-hiv\/hiv-1-subtypes."},{"issue":"8","key":"871_CR47","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/v15081732","volume":"15","author":"FET Foka","year":"2023","unstructured":"Foka FET, Mufhandu HT. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. Viruses. 2023;15(8):1732.","journal-title":"Viruses"},{"issue":"9","key":"871_CR48","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/v16091393","volume":"16","author":"N Geremia","year":"2024","unstructured":"Geremia N, Basso M, De Vito A, Scaggiante R, Giobbia M, Battagin G, Dal Bello F, Giordani MT, Nardi S, Malena M, Cattelan A, Parisi SG. Patterns of Transmitted Drug Resistance Mutations and HIV-1 Subtype Dynamics in ART-Na\u00efve Individuals in Veneto, Italy, from 2017 to 2024. Viruses. 2024;16(9):1393.","journal-title":"Viruses"},{"key":"871_CR49","unstructured":"Gupta, R. K., Jordan, M. R., Sultan, B. J\u2026 Global Trends in Antiretroviral Resistance in Treatment-Na\u00efve Individuals with HIV After Roll-Out of Antiretroviral Therapy in Resource-Limited Settings: A Global Collaborative Study and Meta-Regression Analysis.TheLancet HIV, 2022; 9(5): 15\u201327."},{"key":"871_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874091X01711010105","volume":"11","author":"R Muswe","year":"2017","unstructured":"Muswe R, Oktedalen O, Zhou DT, Zinyando E, Shawarira-Bote S, Stray-Pedersen B, Siziba A, Gomo ZAR. Inflammatory markers and plasma lipids in HIV patients: A correlation analysis study. Open Biochem J. 2017;11:105\u201318.","journal-title":"Open Biochem J"},{"key":"871_CR51","doi-asserted-by":"publisher","first-page":"848630","DOI":"10.3389\/fimmu.2022.848630","volume":"13","author":"S Serrano-Villar","year":"2022","unstructured":"Serrano-Villar S, L\u00f3pez-Huertas MR, Jim\u00e9nez D, Galera C, Mart\u00ednez-Sanz J, Moreno E, Muriel A, Guti\u00e9rrez F, Busca C, Portilla J, Bisbal O, Iribarren JA, Tejerina F, de los Santos I, Moreno S. Long-term changes of inflammatory biomarkers in individuals on suppressive three-drug or two-drug antiretroviral regimens. Front Immunol. 2022;13:848630.","journal-title":"Front Immunol"},{"issue":"1","key":"871_CR52","first-page":"1","volume":"6","author":"SG Deeks","year":"2020","unstructured":"Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Reviews Disease Primers. 2020;6(1):1\u201322.","journal-title":"Nat Reviews Disease Primers"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00871-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00871-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:03:18Z","timestamp":1790686998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00871-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00871-3","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the Declaration of Helsinki and Nigerian HIV research ethical guidelines. Written informed consent was obtained from all participants prior to enrolment. This study also adhered to Nigerian HIV research ethics standards, incorporating community-aligned protocols and rigorous oversight. Ethical approval was secured from the Health Research Ethics Committee (HREC) of IBB Specialist Hospital Minna (certificate No. IBBSH\/SUB\/615\/M2023-07), with additional alignment to Nigeria\u2019s National HIV Research Policy requirements for community-inclusive design.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"91"}}